CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Umayana has developed a new formulation to prevent and treat oral mucositis in cancer patients, a common and painful side effect of cancer therapies. This innovative solution aims to address the root causes rather than just manage symptoms.
Cancer is a devastating and costly condition expected to increase significantly by 2030.
According to the 2018 WHO report, the global cancer burden is estimated at 18.1 million new cases annually .
Mucositis is a condition in cancer patients that manifests as severe ulcerations in the mouth and the gastrointestinal tract.
Oral mucositis (OM) is cancer treatment's most significant side effect worldwide .
Mucositis can be caused by chemotherapy and/or radiotherapy.
It occurs in nearly 40% of patie…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
